Foresite Capital Management II’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,605,499
| Closed | -$54.6M | – | 6 |
|
|
2019
Q3 | $54.6M | Sell |
2,605,499
-121,069
| -4% | -$2.54M | 11.53% | 2 |
|
|
2019
Q2 | $56.8M | Hold |
2,726,568
| – | – | 31.92% | 1 |
|
|
2019
Q1 | $60.9M | Sell |
2,726,568
-242,081
| -8% | -$5.41M | 27.51% | 2 |
|
|
2018
Q4 | $71M | Sell |
2,968,649
-332,148
| -10% | -$7.94M | 37.63% | 1 |
|
|
2018
Q3 | $90M | Sell |
3,300,797
-55,952
| -2% | -$1.53M | 33.33% | 2 |
|
|
2018
Q2 | $90.3M | Buy |
3,356,749
+36,804
| +1% | +$990K | 31.8% | 2 |
|
|
2018
Q1 | $106M | Buy |
3,319,945
+219,799
| +7% | +$7M | 35.15% | 1 |
|
|
2017
Q4 | $117M | Sell |
3,100,146
-720,316
| -19% | -$27.2M | 40.96% | 1 |
|
|
2017
Q3 | $94.7M | Sell |
3,820,462
-172,055
| -4% | -$4.27M | 38.39% | 1 |
|
|
2017
Q2 | $82.1M | Hold |
3,992,517
| – | – | 37.61% | 2 |
|
|
2017
Q1 | $86.8M | Buy |
3,992,517
+156,687
| +4% | +$3.4M | 37.22% | 1 |
|
|
2016
Q4 | $78.4M | Sell |
3,835,830
-132,070
| -3% | -$2.7M | 39.37% | 1 |
|
|
2016
Q3 | $59.5M | Hold |
3,967,900
| – | – | 28.42% | 2 |
|
|
2016
Q2 | $42.9M | Sell |
3,967,900
-120,000
| -3% | -$1.3M | 29.35% | 1 |
|
|
2016
Q1 | $55.4M | Hold |
4,087,900
| – | – | 27.13% | 1 |
|
|
2015
Q4 | $75.4M | Hold |
4,087,900
| – | – | 25.29% | 1 |
|
|
2015
Q3 | $104M | Buy |
+4,087,900
| New | +$104M | 31.43% | 1 |
|